Armata Pharmaceuticals (ARMP) Retained Earnings (2016 - 2018)
Historic Retained Earnings for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q3 2018 value amounting to -$402.0 million.
- Armata Pharmaceuticals' Retained Earnings fell 258.82% to -$402.0 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$402.0 million, marking a year-over-year decrease of 258.82%. This contributed to the annual value of -$394.2 million for FY2017, which is 336.85% down from last year.
- Armata Pharmaceuticals' Retained Earnings amounted to -$402.0 million in Q3 2018, which was down 258.82% from -$400.4 million recorded in Q2 2018.
- Armata Pharmaceuticals' 5-year Retained Earnings high stood at -$360.3 million for Q3 2015, and its period low was -$402.0 million during Q3 2018.
- For the 5-year period, Armata Pharmaceuticals' Retained Earnings averaged around -$379.9 million, with its median value being -$381.4 million (2016).
- Per our database at Business Quant, Armata Pharmaceuticals' Retained Earnings skyrocketed by 600.05% in 2014 and then crashed by 584.33% in 2017.
- Quarter analysis of 5 years shows Armata Pharmaceuticals' Retained Earnings stood at -$362.0 million in 2014, then dropped by 0.14% to -$362.5 million in 2015, then decreased by 5.2% to -$381.4 million in 2016, then dropped by 3.37% to -$394.2 million in 2017, then decreased by 1.98% to -$402.0 million in 2018.
- Its Retained Earnings was -$402.0 million in Q3 2018, compared to -$400.4 million in Q2 2018 and -$397.3 million in Q1 2018.